Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial. (Q51547763)
Jump to navigation
Jump to search
scientific article published in July 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial. |
scientific article published in July 2011 |
Statements
1 reference
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial. (English)
1 reference
1 reference
Beatriz Grinsztejn
1 reference
Michael Saag
1 reference
Jean-Michel Molina
1 reference
Sharon Walmsley
1 reference
Katia Boven
1 reference
Simon Vanveggel
1 reference
Pedro Cahn
1 reference
Khuanchai Supparatpinyo
1 reference
Herta Crauwels
1 reference
Laurence T Rimsky
1 reference
ECHO study group
1 reference
1 July 2011
1 reference
1 reference
378
1 reference
238-246
1 reference
9787
1 reference
Identifiers
1 reference